title: Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013.
abstract: With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the SCAI publications committee concisely summarizes and provides editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice. © 2014 Wiley Periodicals, Inc.
authors.affiliation: Stanford University Medical Center, Stanford, California.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Tremmel
authors.forename: Rajan A G
authors.initials: RA
authors.lastname: Patel
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: Mehmet
authors.initials: M
authors.lastname: Cilingiroglu
authors.forename: Duane S
authors.initials: DS
authors.lastname: Pinto
authors.forename: Larry S
authors.initials: LS
authors.lastname: Dean
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
mesh_terms: D006328:Cardiac Catheterization; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D002406:Catheterization, Peripheral; D002986:Clinical Trials as Topic; D003935:Diagnostic Techniques, Cardiovascular; D057510:Endovascular Procedures; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D062645:Percutaneous Coronary Intervention; D011237:Predictive Value of Tests; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents
keywords: antithrombotics; myocardial infarction; peripheral arterial disease; review; stents; valvular heart disease